Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 1,421 shares at $20.20 ($29K) on 2023-01-05, disclosed to the SEC on 2023-01-05.
Seasonal sale ($29k) by Chief Scientific Officer — this insider has traded OPNT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |
| OPNT | SELL | 2022-01-12 | $12K | — | Filing → |